Introduction of Egyptian Journal of Medical Human Genetics:
The Egyptian Organization for Biological Products and Vaccines (VACSERA) is considered one of the main research centres in Egypt and the Middle East area for the production of vaccines, sera and biological products. VACSERA has current manufacturing facilities for oral poliovaccine, bacille Calmett_Guérin, diphtheria-tetanus-pertussis vaccine, albumin, γ-globulins and other vaccines, blood components and & fractions. The main responsibilities of VACSERA are to serve the government and the trade sector requirements regarding vaccines, sera and biological products, through local production and/or importation.
1 | Country: | Egypt |
Institute: | Ain Shams University Centre for Genetic Engineering and Biotechnology (ACGEB) | |
Address: | Ain Shams University, Abassya, Cairo, Egypt | |
Tel: | 2026837862 | |
Fax: | 2024837888 | |
Email: | This email address is being protected from spambots. You need JavaScript enabled to view it. | |
Head: | Prof. Wagida Anwar | |
Focus of interest: | 1) Disease diagnostic; 2) Vaccine Development; 3) Bioinformatics | |
Key Technical Fecilities: | 1) Two Dimensional electrophoresis; 2) DHPLC; 3) PCR (RNA or DNA);4) DNA sequencer | |
Training Fecilities: | ||
Short-term: | Molecular biology/genetics | |
2 | Country: | Egypt |
Institute: | Genetic Engineering and Biotechnology Research Institute (GEBRI), Alexandria | |
Address: | Protein Research Department, GEBRI, Mubarak City, New Borg El Arab, Alexandria, Egypt | |
Tel: | 203 45 93 420 | |
Fax: | 203 45 93 423 | |
Email: | This email address is being protected from spambots. You need JavaScript enabled to view it. | |
Head: | Prof. Dr. Medhat Saif El Nasr | |
Focus of interest: | 1) Drugs, Therapeutics and Products | |
Key Technical Fecilities: | 1) Two Dimensional electrophoresis; 2) DHPLC; 3) PCR (RNA or DNA); 4) DNA sequencer; 5) GC Mass; 6) Fermentation; 7) Recombinant drug production; 8) Recombinant vaccine production; 9) Non- Recombinant vaccine production;10) Bioinformatics centre | |
Other Fecilities: | Structure Biology; CHEF electrophoresis; Peptide synthesizer; Oligo Synthesizer | |
Training Fecilities: | ||
Short-term: | 1) Biotechnology; 2) Molecular biology/genetics | |
Long-term: | Ph.D. & M.Sc. | |
3 | Country: | Egypt |
Institute: | Holding Comapany for biological Products and Vaccines, VACSERA – The Egyptian Company for Biotech Industries-EGYTEC | |
Address: | 51 Wezaret Al Zeraa St. Agouza Giza –Egypt | |
Tel: | 2027611111 | |
Fax: | 2023483187 | |
Email: | This email address is being protected from spambots. You need JavaScript enabled to view it. | |
Website: | http://www.vacsera.com | |
Head: | Dr. Mohammed Ali S. Abadi | |
Focus of interest: | 1) Drugs, Therapeutics and Products; 2) Vaccine Development; 3) Bioinformatics | |
Key Technical Fecilities: | 1) Micro array; 2) High density array; 3) Two Dimensional electrophoresis; 4) DHPLC; 5) PCR (RNA or DNA); 6) DNA sequencer; 7) GC Mass; 8) Fermentation; 9) Recombinant drug production; 10) Recombinant vaccine production; 11) Non- Recombinant vaccine production; 12) Bioinformatics centre | |
4 | Country: | Egypt |
Institute: | National Hepatology and Tropical Medicine Research Institute, Cairo | |
Address: | 10 Kasr El-Eini St., Cairo, 11441. | |
Tel: | 202 3688400 | |
Fax: | 202 3682774 | |
Email: | This email address is being protected from spambots. You need JavaScript enabled to view it. | |
Head: | Prof. Mohamed Abdel Hamid | |
Focus of interest: | 1) Disease diagnostic | |
Key Technical Fecilities: | 1) Micro array; 2) PCR (RNA or DNA) | |
Training Fecilities: | ||
Short-term: | 1) Clinical techniques/research | |
Long-term: | Ph.D. & M.Sc. | |
5 | Country: | Egypt |
Institute: | National Research Centre, Giza | |
Address: | Behooth St. (ex-Tahrir St.), Dokki, Giza 12311, Egypt | |
Tel: | 2023354971 | |
Fax: | 2023370931 | |
Email: | This email address is being protected from spambots. You need JavaScript enabled to view it. | |
Head: | Prf. Hani El-Nazer | |
Focus of interest: | 1) Disease diagnostic; 2) Drugs, Therapeutics and Products; 3) Vaccine Development; 4) Bioinformatics | |
Key Technical Fecilities: | 1) Two Dimensional electrophoresis; 2) PCR (RNA or DNA); 3) DNA sequencer; 4) Fermentation; 5) Non- Recombinant vaccine production |